Impact of STAS on Lung Resections for Adenocarcinoma: A Retrospective Analysis
Open Access
Abstract
Background: Tumor spread through air spaces (STAS) has been proposed as a histopathological marker of aggressive tumor biology in adenocarcinoma of the lung (ADCL). Its independent prognostic significance and clinical implications regarding surgical strategy remain controversial. This study evaluated clinicopathological correlates and the prognostic impact of STAS in a homogeneous cohort of resected ADCL. Methods: We retrospectively analyzed 100 patients with primary ADCL resected between 2009 and 2018. STAS was classified as absent, low (1–4 clusters), or high (≥5) by an experienced pathologist. Associations between STAS and clinical, surgical, and pathological variables were tested with univariate analyses and multivariable logistic regression. Overall survival (OS) was evaluated using Kaplan–Meier and Cox regression. Results: STAS was present in 46% of tumors and was significantly associated with a higher pathological N category (pN0-pN3; p = 0.005), more advanced UICC stage (p = 0.049), lymphovascular invasion (LVI; p = 0.008), and perineural invasion (PnI; p = 0.012). In univariate survival analysis, patients with STAS had shorter OS than patients without STAS (p = 0.047). After limited resection, OS did not differ (p = 0.864), whereas after radical anatomical resection, patients with STAS showed reduced OS (p = 0.034). In multivariable Cox regression analysis, STAS did not retain independent prognostic significance. Conclusions: STAS is frequent in resected ADCL and correlates with adverse pathological features and reduced OS in univariate models. In multivariate analysis, STAS did not emerge as an independent prognostic factor. These findings support the interpretation of STAS as a marker of aggressive tumor biology rather than an independent determinant of prognosis or surgical decision-making.Keywords
This publication has 27 references indexed in Scilit:
- Efficacy of Adjuvant Chemotherapy in Stage IA Lung Adenocarcinoma with Tumor Spread Through Air Spaces: A Multi-Center Real-World StudyClinical Lung Cancer, 2025
- Which descriptor should spread through air spaces (STAS) be incorporated into? T descriptor versus residual tumor classificationThe Journal of Pathology: Clinical Research, 2025
- STAS: New explorations and challenges for thoracic surgeonsClinical and Translational Oncology, 2024
- Pro: “Is Spread Through Air Spaces an In Vivo Phenomenon or an Inducible Artifact?”Journal of Thoracic Oncology, 2024
- Spread Through Air Spaces (STAS) Is Prognostic in Atypical Carcinoid, Large Cell Neuroendocrine Carcinoma, and Small Cell Carcinoma of the LungJournal of Thoracic Oncology, 2019
- Lobectomy Is Associated with Better Outcomes than Sublobar Resection in Spread through Air Spaces (STAS)-Positive T1 Lung Adenocarcinoma: A Propensity Score–Matched AnalysisJournal of Thoracic Oncology, 2019
- Spread Through Air Spaces Is a Prognostic Factor in Sublobar Resection of Non-Small Cell Lung CancerThe Annals of Thoracic Surgery, 2018
- Significance of Spread Through Air Spaces in Resected Pathological Stage I Lung AdenocarcinomaThe Annals of Thoracic Surgery, 2018
- Semiquantitative Assessment of Tumor Spread through Air Spaces (STAS) in Early-Stage Lung AdenocarcinomasJournal of Thoracic Oncology, 2017
- Spread through Air Spaces (STAS) Is an Independent Predictor of Recurrence and Lung Cancer–Specific Death in Squamous Cell CarcinomaJournal of Thoracic Oncology, 2017